A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT01184287 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Program discontinued

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Ranpirnase

Sponsor

Tamir Biotechnology, Inc.